-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Jounce Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2016 to Q4 2022.
- Jounce Therapeutics, Inc. General and Administrative Expense for the quarter ending December 31, 2022 was $8.46M, a 17.5% increase year-over-year.
- Jounce Therapeutics, Inc. General and Administrative Expense for the twelve months ending December 31, 2022 was $31M, a 6.85% increase year-over-year.
- Jounce Therapeutics, Inc. annual General and Administrative Expense for 2022 was $31M, a 6.85% increase from 2021.
- Jounce Therapeutics, Inc. annual General and Administrative Expense for 2021 was $29M, a 0.76% increase from 2020.
- Jounce Therapeutics, Inc. annual General and Administrative Expense for 2020 was $28.8M, a 3.03% increase from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)